Short acting GLP-1 receptor agonist (injectable)
Beinaglutide flexible dose injection three times daily
BEIN_SC_FLEX_0p1-0p2_TID
Effects across outcomes
Bayesian random effects estimate against the comparator of each analysis (usually placebo), posterior median and 95% credible interval. Green: clearly better; red: clearly worse.
| Condition | Outcome | Window | Versus | Effect (95% CrI) | SUCRA |
|---|---|---|---|---|---|
| Type 2 diabetes (adults) | HbA1c change | weeks 20 to 36 (target week 26) | Placebo | MD -0.98 (-2.08 to 0.17) | 0.57 |
| Type 2 diabetes (adults) | Body weight change in kilograms (diabetes) | weeks 20 to 36 (target week 26) | Placebo | MD -2.71 (-8.62 to 3.26) | 0.70 |